Home › Thyroid Cancer › District of Columbia
Thyroid Cancer clinical trials in District of Columbia
5 studies for Thyroid Cancer are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Georgetown University Lombardi Cancer Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT05786924Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients
- Georgetown University, Washington D.C.
Recruiting
Ages 18 and older · All sexes · Updated Jan 16, 2026 · NCT06853925Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer
- Lombardi Comprehensive Cancer Center, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
Recruiting
Ages 18 and older · All sexes · Updated Jan 8, 2026 · NCT06980103Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
- MedStar Washington Hospital Center, Washington D.C.
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Dec 12, 2024 · NCT05668962From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.